Skip to main content
SpringerLink
Log in

Wem hilft der neoadjuvante Androgenentzug?

  • Kontroversen in der Uro-Onkologie
  • Published:
Der Urologe B

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Vallett BS (1944) Radical perineal prostatectomy subsequent to bilateral orchiectomy. Del Med J 16: 19–23

    Google Scholar 

  2. Scott WW, Boyd HL (1969) Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate. A retrospective study based upon 25 years of experience. J Urol 101: 86–92

    CAS  PubMed  Google Scholar 

  3. Tetu B, Srigley JR, Boivin JC et al (1991) Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma: a histopathologic and immunohistochemical study. Am J Surg Pathol 15: 111–120

    Article  CAS  PubMed  Google Scholar 

  4. Murphy WM, Soloway MS, Barrows GH (1991) Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer 68: 821–828

    Article  CAS  PubMed  Google Scholar 

  5. Vaillancourt L, Tetu B, Fradet Y et al (1996) Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma: a randomized study. Am J Surg Pathol 20: 86–93

    Article  Google Scholar 

  6. Labrie F, Cusan L, Gomez JL et al (1994) Downstaging of early stage prostate cancer before radical prostatectomy: the first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist. Urology 44: 29–37

    Article  Google Scholar 

  7. Soloway MS, Sharifi R, Wajsman Z et al (1995) Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMo) prostate cancer. J Urol 424–428

  8. Goldenberg SL, Klotz LH, Jewett MAS et al (1995) Randomized, controlled study of neoadjuvant reversible androgen withdrawal therapy with cyproterone acetate in the surgical management of localized prostate cancer. J Urol 153: 254

    Google Scholar 

  9. Debruyne FMJ, Witjes WPJ, Schulman CC et al (1994) A multicentric trial of combined neoadjuvant androgen blockade with zoladex and flutamide prior to radical prostatectomy in prostate cancer. Eur Urol 26: 4

    PubMed  Google Scholar 

  10. Van Poppel H, de Ridder D, Elgamal AA, Van de Voorde W, Werbrouck P, Ackaert K, et al (1995) Neoadjuvant hormonal therapy before radical prostatectomy decreases the number of positive surgical margins in stage T2 prostate cancer: interim results of a prospective randomized trial. J Urol 154: 429–434

    Article  PubMed  Google Scholar 

  11. Fair WR, Aprikian A, Sogani P, Reuter V, Whitmore WF Jr (1993) The role of neoadjuvant hormonal manipulation in localized prostatic cancer. Cancer 71: 1031–1038

    Article  CAS  PubMed  Google Scholar 

  12. Tunn UW, Goldschmidt AJW (1992) Effekte der neoadjuvanten medikamentösen kompletten Androgendeprivation vor radikaler Prostatektomie. In: Jocham D (Hrsg) Aktuelle Aspekte des Prostatakarzinoms. Thieme, Stuttgart, S 31–38

    Google Scholar 

  13. Mottrie AM, Mappes C, Stockle M et al (1993) Neoadjuvant hormonal treatment in clinical stage C prostate cancer. J Urol 149: 347

    Google Scholar 

  14. Daneshgari F, Crawford ED, Andres E et al (1993) Neoadjuvant hormonal therapy of patients with clinical stage C prostate cancer. J Urol 149: 348

    Google Scholar 

  15. Pummer K, Crawford ED, Daneshgari F, Andres E, Pfister S, Miller GJ (1994) Hormonal pretreatment does not affect the final pathologic stage in locally advanced prostate cancer. Urology 44: 38–42

    Article  Google Scholar 

  16. Van de Voorde WM, Elgamal AA, Van Poppel HP et al (1994) Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. Cancer 74: 3164–3175

    Article  PubMed  Google Scholar 

  17. Abbas F, Scardino PT (1996) Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol Clin North Am 23: 587–604

    Article  CAS  PubMed  Google Scholar 

  18. Partin AW, Pound CR, Clemens JQ et al (1993) Serum PSA after anatomic radical prostatectomy: the John Hopkins experience after 10 years. Urol Clin North Am 20: 713–725

    CAS  PubMed  Google Scholar 

  19. Zagars GK, von Eschenbach AC, Johnson DE et al (1987) Stage C adenocarcinoma of the prostate: an analysis of 551 patients treated with external beam radiation. Cancer 60: 1489–1499

    Article  CAS  PubMed  Google Scholar 

  20. Paulson DF, Moul JW, Walther PJ (1990) Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 144: 1180–1184

    CAS  PubMed  Google Scholar 

  21. Epstein JI, Carmichael M, Partin AW et al (1993) Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 149: 1478–1485

    CAS  PubMed  Google Scholar 

  22. Gleave ME, Goldenberg SL, Jones EC et al (1995) Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer. J Urol 155: 213–219

    Article  Google Scholar 

  23. Zelefsky MJ, Leibel SA, Burman CM et al (1994) Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformai radiation therapy. Int J Radiat Oncol Biol Phys 29: 755–761

    Article  CAS  PubMed  Google Scholar 

  24. Pilepich MV, Krall JM, al-Sarraf M et al (1995) Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45: 616–623

    Article  CAS  PubMed  Google Scholar 

  25. Laverdiere J, Gomez JL, Cusan L et al (1995) Beneficial effect of combination therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 32: 189

    Article  Google Scholar 

  26. Bolla M, Gonzalez D, Warde P et al (1997) Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337: 295–300

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Urologie, Auenbruggerplatz 7, A-8036, Graz

    K. Pummer, H. Trummer, H. Augustin & G. Hubmer

Authors
  1. K. Pummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Trummer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Augustin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Hubmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pummer, K., Trummer, H., Augustin, H. et al. Wem hilft der neoadjuvante Androgenentzug?. Der Urologe B 38, S41–S45 (1998). https://doi.org/10.1007/s001310050373

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001310050373

Search

Navigation